BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 13, 2009
View Archived Issues
NuPathe reports phase III results for Zelrix transdermal patch for migraine
Read More
FDA Advisory Committee recommends GE Healthcare's DaTSCAN
Read More
Ikaria to in-license worldwide rights to investigational fibrin-derived peptides
Read More
Javelin reports phase III results for intranasal ketamine in pain
Read More
Genmab presents preliminary topline results for Arzerra in CLL
Read More
Nycomed and Forest to collaborate on roflumilast for COPD
Read More
In vivo pharmacokinetics and metabolism data on afobazole presented at EACPT
Read More
Squalene synthase inhibitors display preclinical anti-atherosclerotic activity in recent study
Read More
Dako collaborates with Genentech on diagnostic tests for gastric cancer
Read More
PARP inhibitor PJ-34 reduces tPA-induced intracerebral hemorrhage in ischemic mice
Read More
Novel VEGF inhibitor NP-184 displays anti-angiogenic activity in preclinical study
Read More
Antithrombotic effects and improved safety shown by AVE-5026 in animal models
Read More
Wyeth receives notice from FDA for extended Prevnar 13 action date
Read More
Preliminary phase I and I/II data suggest safety and clinical activity of IMGN-901 in SCLC
Read More
Multaq approved in Canada for atrial fibrillation
Read More
Opexa enters into stem cell agreement with Novartis
Read More
Forest and AstraZeneca to codevelop and commercialize ceftaroline
Read More
Abbott discloses histamine H3 receptor ligands for the treatment of ADHD
Read More
Kissei describes COMT inhibitors for the treatment of Parkinson's disease
Read More
S1P1 receptor agonists in development at GSK
Read More
Sanofi-aventis synthesizes P2Y12 receptor antagonists useful in antiplatelet therapy
Read More
Novel vitamin D3 derivatives reported for the treatment of psoriasis
Read More
Shanghai Hengrui claims DDP IV inhibitors for the treatment of diabetes
Read More
ALK5 inhibitors in early development at Novartis for the treatment of PAH
Read More